RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RAPT is expected to report earnings to fall 85.69% to -9 cents per share on August 07
Q2'25
Est.
$-0.09
Q1'25
Missed
by $0.52
Q4'24
Missed
by $0.82
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.01
The last earnings report on May 08 showed earnings per share of -63 cents, missing the estimate of -12 cents. With 593.03K shares outstanding, the current market capitalization sits at 139.40M.